caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1659539021

Amandeep SalhotraMD

PRACTICECITY OF HOPESee all providers at this practice →
Hematology-OncologyDuarte, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Amandeep Salhotra's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Ko Yamada
Cardiology · Los Angeles, CA
25235
NADEMANEE, AUAYPORN24221
Leslie Popplewell
Hematology · Duarte, CA
22292
Jimmie Wong
Diagnostic Radiology · Duarte, CA
2083
Julie Ressler
Diagnostic Radiology · Duarte, CA
2045
Alexander Jung
Diagnostic Radiology · Duarte, CA
1751
MARX, HOWARD1733
Jasmine Zain
Hematology · Duarte, CA
17130
Alex Herrera
Hematology · Duarte, CA
1330
Joo Song
Pathology · Duarte, CA
1226
ROTTER, ARNOLD1112
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
289
Unique beneficiaries
—
Total services
1,196
Distinct HCPCS
6
Medicare payment
$107K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — below median (cohort median 4,173).
PRESCRIBING · PART D · 2024
Total Rx claims
741
Beneficiaries
—
Total drug cost
$3.1M
Distinct drugs
33
Brand share
36.3%
Top prescribed drugs
Belumosudil Mesylate73 claims
Ruxolitinib Phosphate65 claims
Acyclovir63 claims
Prednisone41 claims
Sulfamethoxazole/Trimethoprim35 claims
QUALITY · MIPS · 2024
Final MIPS score
92.8
Quality
78.5
Cost
70.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.75%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$40K
Payment records
30
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$23K
Consulting Fee$12K
Travel and Lodging$3K
Food and Beverage$922